Can patients with osteoporosis who have taken bisphosphonates for five years discontinue treatment without increasing future fracture risk?
Available evidence suggests that after five years of treatment^ discontinuation of bisphosphonates carries little to no increased future fracture risk. Choosing appropriate patients to continue therapy beyond five years^ and determining when or if to reinitiate therapy in those discontinued^ remains uncertain.
*** Original Documents can be found and downloaded using the link provided below ***
Publication Date: 2013-12-2
Last Updated on PCR: 2017-03-31 15:14:41